Small Chloroquine Study Halted Over Risk of Fatal Heart Complications
A research trial of coronavirus patients in Brazil ended after patients taking a higher dose of chloroquine, one of the drugs President Trump has promoted, developed irregular heart rates. (Source: NYT Health)
Source: NYT Health - April 13, 2020 Category: Consumer Health News Authors: Katie Thomas and Knvul Sheikh Tags: Hydroxychloroquine (Drug) Azithromycin (Drug) Research Coronavirus (2019-nCoV) Drugs (Pharmaceuticals) Manaus (Brazil) Source Type: news

Researchers from Intermountain Healthcare & U of U Health launch vital COVID-19 clinical trials
(Intermountain Medical Center) Researchers from Intermountain Healthcare and University of Utah Health in Salt Lake City have launched two vital clinical trials to test the effectiveness and safety of two drugs -- hydroxychloroquine (HCQ) and azithromycin -- to treat patients with COVID-19. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - April 13, 2020 Category: Infectious Diseases Source Type: news

Clinical Trial Explores Azithromycin, Hydroxychloroquine Combo as COVID-19 Treatment
Rutgers Cancer Institute of New Jersey will be conducting a clinical trial assessing whether azithromycin combined with hydroxychloroquine is better than hydroxychloroquine alone as a potential treatment for patients diagnosed with COVID-19. (Source: CancerNetwork)
Source: CancerNetwork - April 11, 2020 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news

Hydroxychloroquine And Azithromycin For COVID-19: Benefits TBD, Risks Clear
In the midst of a pandemic, lots of people have ideas for cures. We are desperate for therapies and the virus can be deadly. The problem is that the presumptive cure can add danger to the disease, rather than mitigate it. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - April 10, 2020 Category: Pharmaceuticals Authors: Harlan Krumholz, Contributor Source Type: news

Cardiology Groups Push Back on Hydroxychloroquine, Azithromycin for COVID-19 Cardiology Groups Push Back on Hydroxychloroquine, Azithromycin for COVID-19
In a joint statement, leading cardiology associations urge caution with the use of these treatments in patients with COVID-19 and CVD.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - April 9, 2020 Category: Consumer Health News Tags: Cardiology News Source Type: news

Clinical trial launches to evaluate antimalarial drugs for COVID-19 treatment
(Washington University School of Medicine) Washington University School of Medicine in St. Louis is launching a clinical trial for patients hospitalized with COVID-19 at Barnes-Jewish Hospital. The trial will investigate the effectiveness of different combinations of the antimalarial drugs chloroquine and hydroxychloroquine and the antibiotic azithromycin in treating ill patients infected with the novel coronavirus. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 9, 2020 Category: International Medicine & Public Health Source Type: news

University of Utah Health and Intermountain Healthcare launch COVID-19 clinical trials
(University of Utah Health) Researchers from Intermountain Healthcare and University of Utah Health in Salt Lake City have launched two vital clinical trials to test the effectiveness and safety of two drugs -hydroxychloroquine (HCQ) and azithromycin - to treat patients with COVID-19 (infection with the novel coronavirus). (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - April 9, 2020 Category: Infectious Diseases Source Type: news

Potential harms of chloroquine, hydroxychloroquine and azithromycin for treating COVID-19
Chloroquine, hydroxychloroquine and azithromycin are being used to treat and prevent COVID-19 despite weak evidence for effectiveness, and physicians and patients should be aware of the drugs' potentially serious adverse events, states a review in CMAJ (Canadian Medical Association Journal). (Source: World Pharma News)
Source: World Pharma News - April 8, 2020 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news

Potential harms of chloroquine, hydroxychloroquine and azithromycin for treating COVID-19
(Canadian Medical Association Journal) Chloroquine, hydroxychloroquine and azithromycin are being used to treat and prevent COVID-19 despite weak evidence for effectiveness, and physicians and patients should be aware of the drugs' potentially serious adverse events, states a review in CMAJ (Canadian Medical Association Journal). (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 8, 2020 Category: International Medicine & Public Health Source Type: news

Touting Virus Cure, ‘Simple Country Doctor’ Becomes a Right-Wing Star
How Dr. Vladimir Zelenko ’s claims for his coronavirus treatment spread from a New York village all the way to President Trump. (Source: NYT Health)
Source: NYT Health - April 2, 2020 Category: Consumer Health News Authors: Kevin Roose and Matthew Rosenberg Tags: Coronavirus (2019-nCoV) Vladimir Zelenko Hydroxychloroquine (Drug) Azithromycin (Drug) Shortages Social Media Drugs (Pharmaceuticals) United States Politics and Government Computers and the Internet Jews and Judaism Fringe Groups and M Source Type: news

Drugs considered for COVID-19 can raise risk for dangerous abnormal heart rhythms
(Oregon Health& Science University) As some consider treating coronavirus patients with a combination of the malaria drug hydroxychloroquine and the antibiotic azithromycin, cardiologists are advising caution because both medications can increase the risk for dangerous abnormal heart rhythms, which can in turn lead to cardiac arrest. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - April 2, 2020 Category: Infectious Diseases Source Type: news

I ’m a Doctor Recovering From COVID-19. I Can’t Get Over the Government’s Callousness for Human Life
Dr. Laura Mulvey, 33, practices emergency medicine at Maimonides Medical Center in Brooklyn, New York. After spending six days receiving treatment in her own hospital, she is now recovering at home from what is presumed to be COVID-19, though her test was inconclusive. What follows is a lightly-edited transcript of her story as told to TIME. Early on, sometime in February, [COVID-19] was something that people were thinking about. And worried about. Certainly, the worries were not what they are now. But hospital-wise, we had a bit of an earlier jump on it, because we recognized that this was a potential threat. We’re ...
Source: TIME: Health - March 30, 2020 Category: Consumer Health News Authors: Dr. Laura Mulvey Tags: Uncategorized COVID-19 UnitedWeRise20Disaster Source Type: news

azithromycin (Zithromax): Potential COVID-19 Combo Drug
Title: azithromycin (Zithromax): Potential COVID-19 Combo DrugCategory: MedicationsCreated: 12/31/1997 12:00:00 AMLast Editorial Review: 3/30/2020 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - March 30, 2020 Category: Drugs & Pharmacology Source Type: news

Sun Pharma to donate Rs 25 cr worth drugs, sanitisers to fight coronavirus
Sun Pharmaceutical Industries Ltd has committed to donate Rs 25 crore worth of Hydroxychloroquine (HCQS), Azithromycin, other related drugs and hand sanitisers to support India's fight against coronavirus pandemic. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 27, 2020 Category: Pharmaceuticals Source Type: news

President Trump Called Hydroxychloroquine a ‘Game Changer,’ But Experts Warn Against Self-Medicating With the Drug. Here’s What You Need to Know
After President Trump, late last week, expressed great confidence in the promise of a new COVID-19 therapy that combines two existing prescription medications, supplies of these two drugs rapidly began disappearing from pharmacy shelves. The U.S. Food and Drug Administration allowed an Indian company previously restricted from importing drug products into the US to now start manufacturing one of the drugs. And U.S. plants began gearing up to produce enough to meet the surge in demand. But in those few days, a few people who began self medicating with the drugs in an effort to prevent COVID-19 have died, and others have bee...
Source: TIME: Health - March 24, 2020 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 Source Type: news